Product information and disease descriptionProduct descriptionProduct information
American hospital formulary service (AHFS), or other drug classification
2 evidence topics · 2 sources
AHFS classification
No evidence found.
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct information
2 evidence topics · 2 sources
No evidence found.